Nicolás Isambert

14.1k citations

236 papers · 6.8k indexed · 1 hit paper · h-index 45

Impact in

Oncology top 0.5%
- Vascular Tumors and Angiosarcomas
Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment

Papers in

Oncology 133
- Vascular Tumors and Angiosarcomas 32
- Colorectal Cancer Treatments and Studies 27
- Cancer Treatment and Pharmacology 23
- Cancer Immunotherapy and Biomarkers 21
Gastroenterology 23
- Gastrointestinal Tumor Research and Treatment 23

Co-authors: Nicolas Penel Jean‐Yves Blay Rodolfo Lavilla Emmanuelle Bompas Antoîne Italiano Christine Chevreau Sophie Piperno‐Neumann François Bertucci
Journals: Journal of Clinical Oncology (54 papers)Annals of Oncology (40 papers)European Journal of Cancer (11 papers)Cancer Research (7 papers)Cancer Chemotherapy and Pharmacology (7 papers)
Partner nations: France United States Spain

In The Last Decade

Nicolás Isambert

228 papers receiving 6.7k citations

Hit Papers

align trajectories log scale

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study 2018 · 229 citations

Peers

Countries citing papers authored by Nicolás Isambert

Since Specialization

Citations

This map shows the geographic impact of Nicolás Isambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Isambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Isambert more than expected).

Fields of papers citing papers by Nicolás Isambert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Isambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Isambert. The network helps show where Nicolás Isambert may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nicolás Isambert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicolás Isambert Line = papers co-authored together Nicolás Isambert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	1311P Phase II, open-label study of frontline tusamitamab ravtansine with pembrolizumab ± chemotherapy in advanced non-squamous non-small cell lung cancer: Updated results from CARMEN-LC05 trial Annals of Oncology ·Fontal (aide de camp du général d'Arbois). Auteur du texte, Max Herz, Bianca Marie Crudup, J.L. González-Larriba, I Salo, Mulzer, Wenyue Liao, Aymê Christina de Carvalho, Benjamin Némoz, Nicolás Isambert, R Bhavani, P Felgner, Francis Earl Ray, Paola Alejandra Fiorani Celedón, Дмитрий Васильевич Бабаскин, Y Ben Aliz, Batool Natiq, Louis‐Marie Charbonnier, 八谷誠, Francesca Azzato	2024	3
2	Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma New England Journal of Medicine ·Patricia Pautier, Antoîne Italiano, Sophie Piperno‐Neumann, Christine Chevreau, Nicolas Penel, Nelly Firmin, Pascaline Boudou‐Rouquette, François Bertucci, Valérie Lebrun-Ly, Isabelle Ray‐Coquard, Elsa Kalbacher, Emmanuelle Bompas, Olivier Collard, Nicolás Isambert, Cécile Guillemet, María Rios, Axel Le Cesne, Corinne Balleyguier, Mohamed Elkarouri, Florence Duffaud	2024	29
3	Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study Molecular Oncology ·Renaud Sabatier, Cécile Vicier, Séverine Garnier, Arnaud Guillé, Nadine Carbuccia, Nicolás Isambert, Florence Dalenc, Marie Robert, Christelle Lévy, Jihane Pakradouni, José Adélaı̈de, Max Chaffanet, Shuangzhe Li, Émilie Mamessier, François Bertucci, Anthony Gonçalvès	2022	5
4	Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors The Oncologist ·Fabrice Barlési, Nicolás Isambert, Enriqueta Felip, Byoung Chul Cho, Dae Ho Lee, Julio A. Peguero, Guy Jérusalem, Nicolas Penel, Esma Saâda-Bouzid, Pilar Garrido, Christoph Helwig, Daniel Jardenius, Laureen S. Ojalvo, James L. Gulley	2022	25
5	Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group International Journal of Cancer ·Pascaline Boudou‐Rouquette, E. Martin, Emmanuelle Kempf, Nicolas Penel, Maud Toulmonde, Emmanuelle Bompas, Florence Duffaud, Nelly Firmin, François Bertucci, Jean‐Emmanuel Kurtz, L. Chaigneau, Nicolás Isambert, Esma Saâda-Bouzid, Pascale Dubray‐Longeras, Fréderique Larousserie, Philippe Anract, Christine Chevreau, Jean‐Yves Blay, Sophie Piperno‐Neumann, (unknown)	2021	1
6	Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE European Journal of Cancer ·Patrick Schöffski, Jos M Rooijackers, Agnieszka Woźniak, Jean‐Yves Blay, Sandra J. Strauss, Silvia Stacchiotti, Tomasz Świtaj, Veit Bücklein, Michael Leahy, Antoîne Italiano, Nicolás Isambert, Maria Dêbiec‐Rychter, Raf Sciot, E Minguez, Frank M. Speetjens, Axelle Nzokirantevye, Anouk Neven, Bernd Kasper	2021	38
7	Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group International Journal of Cancer ·Atsushi Ono, Mihaela Aldea, Sophie Piperno‐Neumann, Nelly Firmin, Antoîne Italiano, Nicolás Isambert, Jean‐Emmanuel Kurtz, Corinne Delcambre, Jung-Bok Lee, Tapio Ahokas, Christine Chevreau, Emmanuelle Bompas, Christine Le Maignan, Pascaline Boudou‐Rouquette, Axel Le Cesne, Julien Mancini, Jean‐Yves Blay, Florence Duffaud	2021	10
8	Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma Cancers ·Iryna V. Tarasiuk, Christine Chevreau, Andrew J. Rotherham, Lalleska Moreira de Lemos, Caroline Delmas, 欧宏新, Jean‐Yves Blay, Didier Cupissol, Emmanuelle Bompas, Antoîne Italiano, Nicolás Isambert, آرش نکوئی, Nicolas Penel, François Bertucci, Cécile Guillemet, Boka Kumsa, Stéphanie Foulon, Étienne Chatelut, Axel Le Cesne, Fabienne Thomas	2020	3
9	Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy—A Multicenter Study by the French Sarcoma Group American Journal of Roentgenology ·Amandine Crombé, Michèle Kind, Isabelle Ray‐Coquard, Nicolás Isambert, Christine Chevreau, Thierry André, Célèste Lebbé, Axel Le Cesne, Emmanuelle Bompas, Sophie Piperno‐Neumann, Esma Saâda, Amine Bouhamama, Jean‐Yves Blay, Antoîne Italiano, (unknown)	2020	24
10	Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort Journal for ImmunoTherapy of Cancer ·Byoung Chul Cho, Amaury Daste, Alain Ravaud, Sébastien Salas, Nicolás Isambert, Edward F. McClay, Ahmad Awada, Christian Borel, Laureen S. Ojalvo, Christoph Helwig, P. Alexander Rolfe, James L. Gulley, Nicolas Penel	2020	69
11	Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study Clinical Cancer Research ·Maud Toulmonde, Jean‐Yves Blay, Olivier Bouché, Olivier Mir, Nicolas Penel, Nicolás Isambert, Florence Duffaud, Emmanuelle Bompas, Vilius Dranseika, Romain Boidot, Дудко Григорий Алексеевич, François Ghiringhelli, Carlo Lucchesi, Carine Bellera, François Le Loarer, Antoîne Italiano	2019	14
12	Low Cross-Reactivity Between Cisplatin and Other Platinum Salts The Journal of Allergy and Clinical Immunology In Practice ·强景, Laure Favier, C Pernot, 昭子津森, Charlotte Bernigaud, Côme Lepage, Jean–Louis Jouve, Nicolás Isambert, Evelyne Collet	2019	28
13	Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors Clinical Cancer Research ·Daniel D. Von Hoff, Drew Rasco, Elisabeth I. Heath, Pamela N. Münster, Jan H.M. Schellens, Nicolás Isambert, Christophe Le Tourneau, Bert H. O’Neil, Ron H.J. Mathijssen, José A. López-Martín, W. Jeff Edenfield, Miguel Martín, Patricia LoRusso, Gordon L. Bray, Jorge DiMartino, Aaron Nguyen, Kejian Liu, Eric Laille, Johanna C. Bendell	2018	27
14	Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma group. PubMed ·Alexandre de Nonneville, Engy Abd-El Wahab, Jean‐Yves Blay, Dominique Ranchère, 阿部敬悦, Antoîne Italiano, Sylvie Bonvalot, Silvia Regina Pontes Lopes, Florence Duffaud, François Bertucci, Didier Cupissol, Nicolás Isambert, 瑛夫寺西, Jean‐Michel Coindre, Sébastien Salas	2018	1
15	PHARMACOKINETICS AND SAFETY OF OLAPARIB IN PATIENTS WITH ADVANCED SOLID TUMORS AND HEPATIC OR RENAL IMPAIRMENT Clinical Pharmacology & Therapeutics ·Christian Rolfo, Judith de Vos‐Geelen, Nicolás Isambert, L Rhoda Molife, Jan H.M. Schellens, Jacques De Grève, Jean‐Yves Blay, L. Dirix, Márton Sulyok, Antoîne Italiano, Guy Jérusalem, Thijs Delnoij, Karin Leunen, Morten Mau‐Sørensen, Ruth Plummer, Maria Learoyd, Nigel Baker, Anitra Fielding, Alain Ravaud	2017	1
16	Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial The Lancet Oncology ·Axel Le Cesne, Jean‐Yves Blay, Julien Dômont, Emmanuelle Tresch‐Bruneel, Christine Chevreau, François Bertucci, Corinne Delcambre, Esma Saâda-Bouzid, Sophie Piperno‐Neumann, Jacques‐Olivier Bay, Olivier Mir, Isabelle Ray‐Coquard, Thomas Ryckewaert, Thibaud Valentin, Nicolás Isambert, Antoîne Italiano, Stéphanie Clisant, Nicolas Penel	2015	63
17	Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Refractory Cancer Patients: Shiva Design Annals of Oncology ·C. Le Tourneau, Maud Kamal, Olivier Trédan, Michał Mikulski, Mario Campone, A. Gonçalves, Nicolás Isambert, Céline Gavoille, David Gentien, Nicolas Servant, Thomas Rio Frio, Xavier Paolettí	2013	0
18	Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors Clinical Cancer Research ·Nicolás Isambert, Gilles Freyer, Sylvie Zanetta, Benoît You, P. Fumoleau, Claire Falandry, Laure Favier, Sylvie Assadourian, Karen Soussan-Lazard, SR ANDERSON, V. Trillet-Lenoir	2012	31
19	Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO) The Oncologist ·Isabelle Ray‐Coquard, Antoîne Italiano, Emmanuelle Bompas, Axel Le Cesne, Y Robin, Christine Chevreau, Jacques‐Olivier Bay, Guilhem Bousquet, Sophie Piperno‐Neumann, Nicolás Isambert, L. Lemaître, Charles Fournier, Eric Gauthier, Olivier Collard, Didier Cupissol, Stéphanie Clisant, Jean‐Yves Blay, Nicolas Penel, (unknown)	2012	148
20	Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer The Breast ·Laure Favier, Nicolás Isambert, Sylvie Zanetta, Emmanuelle Ferrant, F. Mayer, Bruno Chauffert, P. Fumoleau, Alesya Gargaeva, 张三萍, Bruno Coudert	2007	6

About Nicolás Isambert

Nicolás Isambert is a scholar working on Oncology, Gastroenterology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cancer Research, having authored 236 papers that have together received 6.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (72 papers), Vascular Tumors and Angiosarcomas (32 papers), Lung Cancer Treatments and Mutations (30 papers), Colorectal Cancer Treatments and Studies (27 papers), Cardiac tumors and thrombi (25 papers), Gastrointestinal Tumor Research and Treatment (23 papers), Cancer Treatment and Pharmacology (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). The work is most often cited by research in Oncology (3.0k citations), Pulmonary and Respiratory Medicine (3.3k citations), Gastroenterology (332 citations), Rheumatology (868 citations) and Cardiology and Cardiovascular Medicine (1.2k citations). Nicolás Isambert has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Nicolas Penel, Jean‐Yves Blay, Rodolfo Lavilla, Emmanuelle Bompas, Antoîne Italiano, Christine Chevreau, Sophie Piperno‐Neumann, François Bertucci, Isabelle Ray‐Coquard and Florence Duffaud. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Research and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact